Brock Lesnar’s doping case has finally been settled. The United States Anti-Doping Agency (USADA) announced on Wednesday they’ve suspended the former UFC heavyweight champion for one year due to failed drug tests in conjunction with his return fight at UFC 200 last July.
Lesnar tested positive for clomiphene and its metabolite, 4-hydroxyclomiphene, in two drug tests administer by the USADA prior to his return to the Octagon. The first on June 28, 2016 and the second the day of his fight on July 9, 2016.
Lesnar went on to defeat Mark Hunt by unanimous decision at UFC 200, a decision that was overturned to no contest last month when he was also suspended one year by the Nevada Athletic Commission (NAC) last month and fined $250,000.
He was under WWE contract when he tested positive and remains under WWE contract today. Lesnar will participate in the 30-man WWE Royal Rumble match at the company’s pay-per-view later this month and is expected to face Goldberg at Wrestlemania 33.
WWE, who tests performers under their Wellness Policy, has stated publicly Lesnar is not subject to Wellness testing because he is not a full-time performer. Not only was he not disciplined by WWE for testing positive, he went on to compete in a main event match at SummerSlam just over a month after testing positive for a performance-enhancing drug (he beat Randy Orton in a singles match).
Moving forward, Brock will have to remain in the USADA drug-testing pool until the suspension is complete. If he should choose to retire during the time of the ban, it will be frozen and will go back into effect should he choose to pursue fighting once again.